- Home
- DTST vs KYNB Comparison
DTST vs KYNB Comparison
Compare DTST & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DTST | KYNB |
|---|---|---|
| Founded | 2001 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 31.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DTST | KYNB |
|---|---|---|
| Price | $4.29 | $7.43 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.0K | ★ 28.9K |
| Earning Date | 03-30-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8036.56 | N/A |
| EPS | 1.89 | ★ 53.38 |
| Revenue | ★ $25,529,819.00 | $8,298,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.35 | ★ $0.15 |
| Revenue Growth | ★ 260.19 | N/A |
| 52 Week Low | $2.93 | $4.85 |
| 52 Week High | $5.44 | $21.94 |
Technical Indicators
Market Signals| Indicator | DTST | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 37.55 |
| Support Level | $4.10 | $7.50 |
| Resistance Level | $4.95 | $8.25 |
| Average True Range (ATR) | 0.27 | 0.66 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 35.88 | 10.47 |
Price Performance
Historical ComparisonAbout DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.